Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics, 108, E24. presented at the 2001.. (2001).
Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues. J Infect Dis, 202, 1648-1658. presented at the 12/2010. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20979455. (2010).